vaccines

News

Novo Nordisk Foundation puts $260m into vaccine drive

The Novo Nordisk Foundation (NNF) is funding a major new R&D initiative in the area of respiratory infections, with up to DKK 1.8 billion ($260 million) earmarked for

News

AZ agrees $1.1bn deal to buy RSV jab developer Icosavax

Not content with taking on the respiratory syncytial virus (RSV) prevention market with its antibody-based therapy Beyfortus, AstraZeneca has agreed to buy US biotech Icos

R&D

The Oxford R21 malaria vaccine and the imperative of continu...

Malaria, a disease caused by the plasmodium parasite and transmitted through the bite of infected mosquitoes, has been a long-standing global health challenge.

News

CSL, Arcturus get first approval for self-assembling RNA jab

Japan’s medicines regulator has approved the first vaccine based on self-assembling RNA, a spin on the mRNA technology used in current shots, which is designed to deliver greater effi

News

First chikungunya vaccine approved by FDA

Valneva has claimed the accolade of becoming the first drugmaker to win FDA approval for a vaccine for chikungunya virus, a potentially life-threatening mosquito-borne dis

News

Moderna swings to loss as COVID sales slump

Shares in Moderna have been under pressure after the company posted a third-quarter loss of $3.6 billion and a steep fall in COVID-19 vaccine sales, although it still thin

Novo Nordisk Foundation puts $260m into vaccine drive

AZ agrees $1.1bn deal to buy RSV jab developer Icosavax

The Oxford R21 malaria vaccine and the imperative of continu...

CSL, Arcturus get first approval for self-assembling RNA jab

First chikungunya vaccine approved by FDA

Moderna swings to loss as COVID sales slump

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

vaccines

Editor's Picks